![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: HCAR2 |
Gene summary for HCAR2 |
![]() |
Gene information | Species | Human | Gene symbol | HCAR2 | Gene ID | 338442 |
Gene name | hydroxycarboxylic acid receptor 2 | |
Gene Alias | GPR109A | |
Cytomap | 12q24.31 | |
Gene Type | protein-coding | GO ID | GO:0001776 | UniProtAcc | Q8TDS4 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
338442 | HCAR2 | LZE8T | Human | Esophagus | ESCC | 3.25e-09 | 4.57e-01 | 0.067 |
338442 | HCAR2 | LZE20T | Human | Esophagus | ESCC | 9.52e-06 | 3.73e-01 | 0.0662 |
338442 | HCAR2 | LZE21T | Human | Esophagus | ESCC | 1.88e-09 | 9.59e-01 | 0.0655 |
338442 | HCAR2 | P1T-E | Human | Esophagus | ESCC | 6.33e-07 | 9.94e-01 | 0.0875 |
338442 | HCAR2 | P2T-E | Human | Esophagus | ESCC | 5.50e-15 | 7.39e-01 | 0.1177 |
338442 | HCAR2 | P4T-E | Human | Esophagus | ESCC | 1.43e-19 | 9.44e-01 | 0.1323 |
338442 | HCAR2 | P5T-E | Human | Esophagus | ESCC | 2.93e-19 | 7.02e-01 | 0.1327 |
338442 | HCAR2 | P8T-E | Human | Esophagus | ESCC | 5.97e-49 | 1.56e+00 | 0.0889 |
338442 | HCAR2 | P9T-E | Human | Esophagus | ESCC | 3.79e-03 | 2.91e-01 | 0.1131 |
338442 | HCAR2 | P10T-E | Human | Esophagus | ESCC | 7.09e-04 | 1.17e-01 | 0.116 |
338442 | HCAR2 | P11T-E | Human | Esophagus | ESCC | 2.05e-13 | 1.87e+00 | 0.1426 |
338442 | HCAR2 | P12T-E | Human | Esophagus | ESCC | 3.86e-38 | 9.59e-01 | 0.1122 |
338442 | HCAR2 | P15T-E | Human | Esophagus | ESCC | 3.19e-05 | 3.24e-01 | 0.1149 |
338442 | HCAR2 | P20T-E | Human | Esophagus | ESCC | 3.99e-26 | 1.51e+00 | 0.1124 |
338442 | HCAR2 | P21T-E | Human | Esophagus | ESCC | 1.63e-52 | 1.86e+00 | 0.1617 |
338442 | HCAR2 | P22T-E | Human | Esophagus | ESCC | 1.22e-15 | 7.34e-01 | 0.1236 |
338442 | HCAR2 | P23T-E | Human | Esophagus | ESCC | 1.54e-23 | 1.91e+00 | 0.108 |
338442 | HCAR2 | P24T-E | Human | Esophagus | ESCC | 5.64e-06 | 7.48e-01 | 0.1287 |
338442 | HCAR2 | P26T-E | Human | Esophagus | ESCC | 3.71e-76 | 1.91e+00 | 0.1276 |
338442 | HCAR2 | P27T-E | Human | Esophagus | ESCC | 2.74e-30 | 9.85e-01 | 0.1055 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0051222112 | Skin | cSCC | positive regulation of protein transport | 125/4864 | 303/18723 | 3.88e-09 | 1.32e-07 | 125 |
GO:000226229 | Skin | cSCC | myeloid cell homeostasis | 67/4864 | 157/18723 | 3.79e-06 | 5.70e-05 | 67 |
GO:004887229 | Skin | cSCC | homeostasis of number of cells | 104/4864 | 272/18723 | 5.34e-06 | 7.71e-05 | 104 |
Page: 1 2 3 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
HCAR2 | SNV | Missense_Mutation | c.121N>C | p.Gly41Arg | p.G41R | Q8TDS4 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-B6-A0WW-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | PD | |
HCAR2 | SNV | Missense_Mutation | rs201097098 | c.757N>T | p.Arg253Cys | p.R253C | Q8TDS4 | protein_coding | tolerated(0.17) | possibly_damaging(0.806) | TCGA-BH-A18G-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
HCAR2 | insertion | Nonsense_Mutation | novel | c.544_545insAACTACTCCACACTGCAAAGTAAGAAAGAGACACAGACACTGAGC | p.Ile182delinsLysLeuLeuHisThrAlaLysTerGluArgAspThrAspThrGluLeu | p.I182delinsKLLHTAK*ERDTDTEL | Q8TDS4 | protein_coding | TCGA-AN-A0FK-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | ||
HCAR2 | insertion | Frame_Shift_Ins | novel | c.65_66insGAGAAACAGTTGGGCTGTTGCATCGAGT | p.Asp23ArgfsTer11 | p.D23Rfs*11 | Q8TDS4 | protein_coding | TCGA-BH-A0B1-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | adriamycin | SD | ||
HCAR2 | SNV | Missense_Mutation | rs769715682 | c.665N>A | p.Arg222Gln | p.R222Q | Q8TDS4 | protein_coding | tolerated(0.2) | benign(0.312) | TCGA-EA-A3HS-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
HCAR2 | SNV | Missense_Mutation | c.812C>G | p.Ser271Trp | p.S271W | Q8TDS4 | protein_coding | deleterious(0) | probably_damaging(0.994) | TCGA-JW-A5VL-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
HCAR2 | SNV | Missense_Mutation | c.185N>A | p.Ser62Asn | p.S62N | Q8TDS4 | protein_coding | tolerated(0.23) | benign(0.23) | TCGA-MA-AA42-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Unknown | Unknown | SD | |
HCAR2 | SNV | Missense_Mutation | c.733N>T | p.Leu245Phe | p.L245F | Q8TDS4 | protein_coding | tolerated(0.22) | possibly_damaging(0.588) | TCGA-A6-6653-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
HCAR2 | SNV | Missense_Mutation | c.139N>T | p.Leu47Phe | p.L47F | Q8TDS4 | protein_coding | tolerated(0.11) | possibly_damaging(0.612) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR | |
HCAR2 | SNV | Missense_Mutation | c.781N>G | p.Ser261Ala | p.S261A | Q8TDS4 | protein_coding | tolerated(0.88) | benign(0.001) | TCGA-AD-A5EJ-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
338442 | HCAR2 | G PROTEIN COUPLED RECEPTOR, DRUGGABLE GENOME, KINASE | NIACIN RECEPTOR AGONIST | |||
338442 | HCAR2 | G PROTEIN COUPLED RECEPTOR, DRUGGABLE GENOME, KINASE | NIACIN | NIACIN | 25737085 | |
338442 | HCAR2 | G PROTEIN COUPLED RECEPTOR, DRUGGABLE GENOME, KINASE | MK-0354 | CHEMBL456145 | ||
338442 | HCAR2 | G PROTEIN COUPLED RECEPTOR, DRUGGABLE GENOME, KINASE | agonist | 178102416 | ||
338442 | HCAR2 | G PROTEIN COUPLED RECEPTOR, DRUGGABLE GENOME, KINASE | allosteric modulator | 178102419 | ||
338442 | HCAR2 | G PROTEIN COUPLED RECEPTOR, DRUGGABLE GENOME, KINASE | agonist | 178102413 | ||
338442 | HCAR2 | G PROTEIN COUPLED RECEPTOR, DRUGGABLE GENOME, KINASE | agonist | 135649840 | ||
338442 | HCAR2 | G PROTEIN COUPLED RECEPTOR, DRUGGABLE GENOME, KINASE | agonist | 178102418 | ||
338442 | HCAR2 | G PROTEIN COUPLED RECEPTOR, DRUGGABLE GENOME, KINASE | MK-1903 | |||
338442 | HCAR2 | G PROTEIN COUPLED RECEPTOR, DRUGGABLE GENOME, KINASE | agonist | 178102409 |
Page: 1 2 3 4 |